Has Katie Egan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,482 in general payments to Katie Egan, MD across 118 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Katie Egan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Katie Egan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Katie Egan, MD

Plastic and Reconstructive Surgery · Houston, TXNPI 1376905737

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.5% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by TELA Bio, Inc. at 31.4% of the total. 2025 is the largest year on record at $5,068, more than ten times the $125 reported in 2019.

$10,482in general payments, 2019–2025

Across 118 payments — averaging $88.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

TELA Bio, Inc.$3K
AbbVie$1K
Mentor Worldwide LLC$1K
Musculoskeletal Transplant Foundation Inc.$711
RTI Surgical, Inc$532
Integra Lifesciences Corporation$467
plus $3K from 14 others

What the payments were for

Travel & lodging$1622%
Food & beverage$10,32098%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
TELA Bio, Inc.	29	$3,288
AbbVie(2 entities)	12	$1,269
Mentor Worldwide LLC	18	$1,246
Musculoskeletal Transplant Foundation Inc.	8	$711
RTI Surgical, Inc	5	$532
Integra Lifesciences Corporation	13	$467
Polynovo North America LLC	5	$461
Baxter Healthcare	6	$415
Motiva USA, LLC	4	$366
Kls-martin L.p.	2	$308
Davol Inc.	2	$308
Innovation Technologies Inc	3	$194
BD	2	$192
Impedimed, Inc.	1	$170
Bone Support Inc.	1	$150
Johnson & Johnson	1	$131
Bioventus LLC	1	$99
Axogen	2	$76
Stryker	2	$71
Optos, Inc.	1	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$1,945
OviTex 2S$906
NATRELLE SALINE-FILLED BREAST IMPLANTS$676
CORTIVA ALLOGRAFT DERMIS$400
MENTOR MemoryGel Resterilizable Gel Sizer$367
Novosorb BTM$245
INTEGRA$204
ARISTA$154
CERAMENTBONE VOID FILLER$150
CERAMENT G$150
Irrisept$150
Motiva Implant Matrix$145
Phasix Mesh$143
ALLODERM$135
MATRIXMANDIBLE$131
NATRELLE$125
MENTOR CPX 2 Breast Tissue Expander$122
OMNIGRAFT$102
SURGIMEND$102
INTEGRA DERMAL REGENERATION TEMPLATE$102

How this compares

$10,482 in reported general payments places this provider in the 80th percentile of 378 plastic and reconstructive surgery providers in Texas.

See all plastic and reconstructive surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$56,720

Medicare patients

Services billed

184

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Houston

Aldona SpiegelHouston$759K
Charles ButlerHouston$227K
Michael KlebucHouston$204K
Patrick GarveyHouston$117K
Rukmini RednamHouston$113K
Edward ChangHouston$111K
Christi BlakkolbHouston$69K
Justin BroylesHouston$48K
Pablo PadillaHouston$46K
Courtney El-ZokmHouston$29K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →